{"id":"NCT00545753","sponsor":"ParaPRO LLC","briefTitle":"Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice","officialTitle":"A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects >6 Months of Age or Older With Pediculosis Capitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2008-03","completion":"2008-05","firstPosted":"2007-10-17","resultsPosted":"2012-10-11","lastUpdate":"2012-10-11"},"enrollment":558,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Pediculosis"],"interventions":[{"type":"DRUG","name":"Spinosad","otherNames":["Natroba (spinosad) Topical Suspension, 0.9%"]},{"type":"DRUG","name":"Spinosad","otherNames":["Natroba (spinosad) Topical Suspension, 0.9%"]},{"type":"DRUG","name":"Permethrin 1%","otherNames":["NIX Creme Rinse"]}],"arms":[{"label":"A - NatrOVA 1% - no nit combing","type":"EXPERIMENTAL"},{"label":"B - NatrOVA 1% - nit combing required","type":"EXPERIMENTAL"},{"label":"C - NIX","type":"ACTIVE_COMPARATOR"}],"summary":"A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (human head lice).","primaryOutcome":{"measure":"Efficacy of NatrOVA Creme Rinse - 1% Relative to NIX Creme Rinse in Subjects Infested With Head Lice","timeFrame":"Assessment were made 14 days following the final product treatment","effectByArm":[{"arm":"A - NatrOVA 1% - No Nit Combing Required","deltaMin":77,"sd":null},{"arm":"B - NatrOVA 1% - Nit Combing Required","deltaMin":19,"sd":null},{"arm":"C - NIX Applied Per Over the Counter (OTC) Instructions","deltaMin":40,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":294},"commonTop":["Application site erythema","Occular hyperaemia","Application site irritation","Erythema","Eye irritation"]}}